ReviewJournal of human lactation : official journal of International Lactation Consultant Association2026
The Evidence Informing Hypoglycaemia Treatment Thresholds in Asymptomatic, Term, Well Newborns: A Review of Literature and Critical Appraisal of Methodological Challenges.
Review in Journal of human lactation : official journal of International Lactation Consultant Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is worldwide inconsistency in blood glucose level treatment thresholds for hypoglycaemia in healthy, term asymptomatic newborns. Differing testing policies and broader inclusion criteria from maternal conditions have increased the incidence of testing. The use of human milk substitutes to treat hypoglycaemia may adversely influence the establishment of breastfeeding and early bonding between mother and baby. RESEARCH
aimTo determine if current research informs a high-quality evidence-based therapeutic treatment threshold for hypoglycaemia in well, asymptomatic newborns in the first 24 hours of life.
methodsA comprehensive review accessing CINAHL, Medline, Scopus, Web of Science, Cochrane, and CENTRAL databases was performed. Original English-language quantitative studies reporting hypoglycemic treatment thresholds, and their neurodevelopmental outcomes for over 11,000 newborns, were appraised for quality and validity using independent screening and Crowe's Quality Appraisal Tool.
resultsThirteen papers were included with outcomes grouped into two categorical definitions of hypoglycaemia (statistical and neurodevelopmental). Nine of the included studies were assessed as producing low quality evidence, with a moderate to high risk of bias, unreliable methodology, and smaller sample sizes. One study provided high quality evidence, with a sample size of > 1000 newborns, that a blood glucose threshold of 2.09 mmol/L was a potentially safe treatment threshold.
conclusionPublished high quality research is lacking to inform a therapeutic treatment threshold for hypoglycaemia in well, term asymptomatic newborns in the first 24 hours. Current treatment may interfere with breastfeeding and bonding. Rigorous research is required to establish a safe threshold and inform future practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.